Results 271 to 280 of about 28,100,614 (312)

Risk factors for pneumonitis after the combination treatment of immune checkpoint inhibitors and thoracic radiotherapy. [PDF]

BMC Pulm Med
Tang Y, Yu H, Guo S, Yao Y, Zhao J, Zheng B, Wu D, Xia Y, Wei Q, Zhang T.   +9 more
europepmc   +1 more source

Time‐restricted feeding prior to Mycobacterium tuberculosis infection reduces tissue CD4+ T cells with limited impact on bacterial clearance

FEBS Open Bio, EarlyView.
Time‐restricted feeding (TRF) in mice increased liver fatty acid oxidation and decreased fatty acid biosynthesis. These alterations persisted when TRF was discontinued and the host was infected with Mycobacterium tuberculosis. Pre‐exposure to TRF did not alter tissue (lung and spleen) mycobacterial burden but significantly reduced CD3+ T cells in lungs
Ashish Gupta, Nidhi Yadav, Subhasmita Das, R. Rajendra Kumar Reddy, Nupur Sharma, Amol Ratnakar Suryawanshi, Jaswinder Singh Maras, Ranjan Kumar Nanda   +7 more
wiley   +1 more source

Therapeutic inhibition of HBsAg and HBV cccDNA through a novel phased combination treatment: glycine and interferon-α. [PDF]

Gut
Lin C, Huang Y, Ran N, Liu J, Luo L, Zhang X, Zheng X, Xun Z, Xu S, Liu C, Kong X, Feng S, Mao H, Ou Q.   +13 more
europepmc   +1 more source

Biomarkers and ImmuneScores in lung cancer: predictive insights for immunotherapy and combination treatment strategies. [PDF]

Biol Proced Online
Yang X, Luo B, Tian J, Wang Y, Lu X, Ni J, Yang Y, Jiang L, Ren S.   +8 more
europepmc   +1 more source

Repeated responders to bevacizumab combination treatment in recurrent glioblastoma: a retrospective case study. [PDF]

J Neurooncol
Lü MJS, Michaelsen SR, Locallo A, Eickhart-Dalbøge CS, Scheie D, Melchior LC, Weischenfeldt J, Lassen U, Poulsen HS, Urup T.   +9 more
europepmc   +1 more source

Local Visible-Photocatalytic Production of Hydrogen and Warm Heat for Combination Treatment of Pressure Ulcer. [PDF]

Adv Sci (Weinh)
Zhu J, Chen T, Fang W, Zhou D, Ni D, Zhao B, Yang Y, Xu Z, He Q.   +8 more
europepmc   +1 more source

XBP1s Mediates Cross-resistance to Combination Treatment of CDK4/6 Inhibitors plus Endocrine Therapy in Breast Cancer. [PDF]

Adv Sci (Weinh)
Sang Y, Liu S, Zhou X, Chi W, Xiong M, Chen M, Ren H, Liu D, Zhang L, Xue J, Chi Y, Wu J.   +11 more
europepmc   +1 more source

Efficacy of high-dose tigecycline-containing regimens for the combination treatment of carbapenem-resistant Enterobacterales bacteraemia. [PDF]

JAC Antimicrob Resist
Nasomsong W, Wanloptaree P, Vasikasin V.
europepmc   +1 more source

Nivolumab and Ipilimumab Combination Treatment in Advanced Ovarian and Endometrial Clear Cell Cancers: A Nonrandomized Clinical Trial.

JAMA Oncol
Gao B, Carlino MS, Michael M, Underhill C, Marshall H, Gunjur A, So J, Kee D, Antill Y, Lam WS, Chan H, Harrup R, Hamilton A, Grady J, Ballinger M, Tavancheh E, Yoon WH, Palmer J, Thomas D, Wilkie K, Cebon J, Klein O.   +21 more
europepmc   +1 more source